Get started
Work

1152P Cyclin E1 amplification (CCNE1amp) is associated with race and poor outcomes in endometrial cancer (EC)

Year: 2025
Type: article
Study design: Observational Study
DOI: 10.1016/j.annonc.2025.08.1788
Authors: K. Hacker, S. Thomas, M. Lightfoot, R.C. Arend, K.N. Moore, C. Washington, P.H. Thaker, S. Crafton, F. Backes, J. Wright, A.L. Jackson, B.R. Corr, T. Castellano, V. Bae-Jump, G. Maxwell, A.M. Puechl, E. Ko, A.A. Secord, B. Pothuri
Institutions: NYU Langone Health, New York University, Duke Medical Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, University of Alabama at Birmingham Hospital, University of Alabama at Birmingham, UAB Medicine, OU Health Stephenson Cancer Center, University of Oklahoma, Washington University in St. Louis, Gynecologic Oncology Group, Allegheny Health Network, Western Pennsylvania Hospital, The Ohio State University, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, University of Cincinnati, University of Cincinnati Medical Center, University of Colorado Anschutz, University of Colorado Denver, Louisiana State University Health Sciences Center New Orleans, University of North Carolina at Chapel Hill, Inova Health System, Levine Cancer Institute, Abramson Cancer Center, University of Pennsylvania, Duke University Health System, Duke University Hospital
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4415940276
FWCI:
Cites:
Cited by:
Related to: